Ajinomoto Aktie News

CHICAGO & ITASCA, Ill.--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a leader in amino acid science and cell culture innovation and part of Ajinomoto Group, today announced a collaboration to evaluate Ajinomoto Group's StemFit™ stem cell culture products using Syntax Bio's ...

The world's hunger for artificial-intelligence chips is straining the industry's ability to produce the materials they rely on, creating new pressure points that could slow the boom.